News  |  Business  

Biotech in China is just getting started, says Loncar Investments’s CEO

By Bloomberg   |   02 April 2019   |   11:40 am  
Brad Loncar, chief executive officer at Loncar Investments, discusses investing in China’s biotech sector and which companies he likes.
In this article:
investments

You may also like